Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Nevus, Sebaceous of Jadassohn × burosumab × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Oncogenic osteomalacia 1 Nevus, Sebaceous of Jadassohn 1

Interventions

burosumab 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04320316 2022-10-07

ENS

University of Alabama at Birmingham

Phase 4 Completed

1 enrolled 10 charts

Nevus, Sebaceous of Jadassohn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡